Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Short-term Investments: 2017-2019

Historic Short-term Investments for Cogent Biosciences (COGT) over the last 1 years, with Mar 2019 value amounting to $8.0 million.

  • Cogent Biosciences' Short-term Investments rose 19.31% to $8.0 million in Q1 2019 from the same period last year, while for Mar 2019 it was $8.0 million, marking a year-over-year increase of 19.31%. This contributed to the annual value of $22.9 million for FY2018, which is 80.62% up from last year.
  • As of Q1 2019, Cogent Biosciences' Short-term Investments stood at $8.0 million, which was down 65.15% from $22.9 million recorded in Q4 2018.
  • Cogent Biosciences' Short-term Investments' 5-year high stood at $47.7 million during Q2 2018, with a 5-year trough of $6.7 million in Q1 2018.
  • In the last 3 years, Cogent Biosciences' Short-term Investments had a median value of $17.8 million in 2017 and averaged $22.6 million.
  • Data for Cogent Biosciences' Short-term Investments shows a peak YoY skyrocketed of 80.62% (in 2018) over the last 5 years.
  • Over the past 3 years, Cogent Biosciences' Short-term Investments (Quarterly) stood at $12.7 million in 2017, then surged by 80.62% to $22.9 million in 2018, then rose by 19.31% to $8.0 million in 2019.
  • Its Short-term Investments stands at $8.0 million for Q1 2019, versus $22.9 million for Q4 2018 and $37.8 million for Q3 2018.